Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 8718 | 10.65 |
09:34 ET | 1000 | 10.62 |
09:36 ET | 400 | 10.61 |
09:38 ET | 1400 | 10.68 |
09:39 ET | 3600 | 10.725 |
09:41 ET | 933 | 10.7797 |
09:43 ET | 965 | 10.79 |
09:45 ET | 200 | 10.8 |
09:48 ET | 400 | 10.8 |
09:50 ET | 3600 | 10.825 |
09:52 ET | 1150 | 10.7839 |
09:54 ET | 1330 | 10.82 |
09:56 ET | 600 | 10.785 |
09:57 ET | 200 | 10.77 |
09:59 ET | 162 | 10.74 |
10:01 ET | 242 | 10.76 |
10:03 ET | 100 | 10.73 |
10:06 ET | 100 | 10.73 |
10:08 ET | 600 | 10.71 |
10:10 ET | 900 | 10.685 |
10:12 ET | 1051 | 10.71 |
10:14 ET | 500 | 10.72 |
10:17 ET | 200 | 10.73 |
10:19 ET | 200 | 10.72 |
10:21 ET | 1000 | 10.71 |
10:24 ET | 650 | 10.715 |
10:26 ET | 1190 | 10.71 |
10:28 ET | 200 | 10.71 |
10:30 ET | 200 | 10.72 |
10:32 ET | 1800 | 10.68 |
10:33 ET | 1481 | 10.6805 |
10:35 ET | 346 | 10.671 |
10:37 ET | 100 | 10.67 |
10:39 ET | 300 | 10.68 |
10:42 ET | 300 | 10.68 |
10:44 ET | 200 | 10.67 |
10:46 ET | 200 | 10.655 |
10:48 ET | 1915 | 10.665 |
10:50 ET | 406 | 10.68 |
10:51 ET | 537 | 10.71 |
10:53 ET | 680 | 10.725 |
10:55 ET | 400 | 10.72 |
10:57 ET | 1100 | 10.7 |
11:00 ET | 300 | 10.7 |
11:02 ET | 400 | 10.66 |
11:04 ET | 100 | 10.66 |
11:06 ET | 1791 | 10.666 |
11:08 ET | 4296 | 10.65 |
11:09 ET | 100 | 10.645 |
11:11 ET | 1206 | 10.67 |
11:13 ET | 500 | 10.68 |
11:18 ET | 1975 | 10.69 |
11:22 ET | 400 | 10.69 |
11:24 ET | 100 | 10.69 |
11:26 ET | 100 | 10.695 |
11:27 ET | 900 | 10.695 |
11:29 ET | 1796 | 10.71 |
11:31 ET | 100 | 10.705 |
11:33 ET | 916 | 10.7295 |
11:36 ET | 200 | 10.72 |
11:40 ET | 2100 | 10.7 |
11:42 ET | 1293 | 10.68 |
11:44 ET | 100 | 10.68 |
11:45 ET | 100 | 10.68 |
11:47 ET | 300 | 10.665 |
11:49 ET | 300 | 10.65 |
11:51 ET | 616 | 10.64 |
11:54 ET | 300 | 10.61 |
11:56 ET | 200 | 10.615 |
11:58 ET | 900 | 10.62 |
12:02 ET | 1184 | 10.62 |
12:03 ET | 1025 | 10.64 |
12:07 ET | 1936 | 10.65 |
12:09 ET | 1100 | 10.6601 |
12:12 ET | 601 | 10.66 |
12:14 ET | 200 | 10.65 |
12:16 ET | 736 | 10.67 |
12:18 ET | 205 | 10.68 |
12:20 ET | 200 | 10.7 |
12:21 ET | 756 | 10.7 |
12:23 ET | 300 | 10.7 |
12:25 ET | 600 | 10.73 |
12:27 ET | 100 | 10.72 |
12:30 ET | 300 | 10.71 |
12:32 ET | 100 | 10.71 |
12:36 ET | 2881 | 10.67 |
12:38 ET | 200 | 10.675 |
12:39 ET | 700 | 10.68 |
12:43 ET | 100 | 10.68 |
12:45 ET | 500 | 10.7 |
12:48 ET | 300 | 10.685 |
12:50 ET | 300 | 10.66 |
12:52 ET | 500 | 10.66 |
12:54 ET | 1100 | 10.6661 |
12:56 ET | 3896 | 10.64 |
12:57 ET | 400 | 10.62 |
12:59 ET | 1300 | 10.62 |
01:01 ET | 900 | 10.61 |
01:03 ET | 1800 | 10.63 |
01:06 ET | 1100 | 10.63 |
01:10 ET | 500 | 10.615 |
01:12 ET | 1520 | 10.625 |
01:14 ET | 300 | 10.64 |
01:15 ET | 200 | 10.64 |
01:17 ET | 200 | 10.64 |
01:19 ET | 802 | 10.65 |
01:24 ET | 100 | 10.65 |
01:26 ET | 463 | 10.65 |
01:30 ET | 100 | 10.65 |
01:32 ET | 210 | 10.65 |
01:33 ET | 1400 | 10.64 |
01:35 ET | 600 | 10.65 |
01:37 ET | 893 | 10.638 |
01:39 ET | 200 | 10.63 |
01:42 ET | 559 | 10.645 |
01:44 ET | 300 | 10.65 |
01:46 ET | 700 | 10.645 |
01:48 ET | 200 | 10.645 |
01:51 ET | 574 | 10.645 |
01:53 ET | 200 | 10.645 |
01:55 ET | 1700 | 10.67 |
01:57 ET | 1893 | 10.65 |
02:00 ET | 500 | 10.65 |
02:02 ET | 1046 | 10.63 |
02:04 ET | 200 | 10.63 |
02:06 ET | 700 | 10.63 |
02:08 ET | 1204 | 10.63 |
02:13 ET | 300 | 10.625 |
02:15 ET | 1503 | 10.645 |
02:18 ET | 400 | 10.645 |
02:20 ET | 722 | 10.635 |
02:26 ET | 600 | 10.625 |
02:27 ET | 100 | 10.625 |
02:29 ET | 763 | 10.61 |
02:31 ET | 300 | 10.61 |
02:33 ET | 1750 | 10.59 |
02:36 ET | 500 | 10.59 |
02:38 ET | 2404 | 10.58 |
02:40 ET | 5416 | 10.59 |
02:42 ET | 200 | 10.59 |
02:44 ET | 1992 | 10.5601 |
02:45 ET | 2070 | 10.5805 |
02:47 ET | 600 | 10.6 |
02:49 ET | 200 | 10.61 |
02:51 ET | 537 | 10.59 |
02:54 ET | 807 | 10.58 |
02:56 ET | 607 | 10.575 |
02:58 ET | 100 | 10.575 |
03:00 ET | 200 | 10.57 |
03:02 ET | 2444 | 10.5799 |
03:03 ET | 1843 | 10.545 |
03:05 ET | 400 | 10.555 |
03:07 ET | 309 | 10.555 |
03:09 ET | 100 | 10.55 |
03:12 ET | 950 | 10.545 |
03:14 ET | 2180 | 10.54 |
03:16 ET | 1347 | 10.51 |
03:18 ET | 2815 | 10.52 |
03:20 ET | 1046 | 10.51 |
03:21 ET | 2454 | 10.51 |
03:23 ET | 800 | 10.505 |
03:25 ET | 1965 | 10.515 |
03:27 ET | 3024 | 10.52 |
03:30 ET | 1100 | 10.505 |
03:32 ET | 2160 | 10.51 |
03:34 ET | 400 | 10.51 |
03:36 ET | 200 | 10.51 |
03:38 ET | 3268 | 10.515 |
03:39 ET | 1419 | 10.535 |
03:41 ET | 900 | 10.53 |
03:43 ET | 2415 | 10.525 |
03:45 ET | 891 | 10.525 |
03:48 ET | 4186 | 10.525 |
03:50 ET | 2233 | 10.52 |
03:52 ET | 4096 | 10.52 |
03:54 ET | 9169 | 10.53 |
03:56 ET | 5826 | 10.555 |
03:57 ET | 17642 | 10.55 |
03:59 ET | 21434 | 10.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.4B | -2.6x | --- |
Arcus Biosciences Inc | 1.5B | -5.2x | --- |
Immatics NV | 1.2B | -11.1x | --- |
Prothena Corporation PLC | 1.1B | -6.2x | --- |
Ardelyx Inc | 1.6B | -23.4x | --- |
Silence Therapeutics PLC | 1.0B | -17.9x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.52 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 18.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.